Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Cue Biopharma logo — Immune Responses, On Cue

Cue Biopharma

Immune Responses, On Cue

Founded 2014 United States Boston, United States 46 employees Post-IPO Equity Biopharma, Biotechnology +2

General Information

Company Name Cue Biopharma
Founded Year 2014
Location United States Boston, United States
Employees 46
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Cue Biopharma. To contact Cue Biopharma, visit cuebiopharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cue Biopharma compare?

A PDF of Cue Biopharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cue Biopharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cue Biopharma

Cue Biopharma, a clinical-stage biopharmaceutical company, is developing a novel class of injectable biologics to selectively engage and modulate disease-specific T cells directly within the patient’s body. The company’s proprietary platform, Immuno-STAT™ (Selective Targeting and Alteration of T cells) and biologics are designed to harness the body’s intrinsic immune system as T cell engagers without the need for ex vivo manipulation or broad systemic immune modulation.

No funding data available for Cue Biopharma yet.

Cue Biopharma Alternatives & Competitors

View All Alternatives
Cue Biopharma vs
Umoja Biopharma
Umoja Biopharma

Pioneering advanced immunotherapies to empower the body's innate ability to fight cancer by reengine...

Series C
9 employees
Biopharma, Biotechnology
Cue Biopharma vs
Harpoon Therapeutics
Harpoon Therapeutics United States

SPEARHEADING IMMUNOTHERAPIES

Post-IPO Equity
33 employees
Biotechnology, Health Care
Compare Cue Biopharma vs Harpoon Therapeutics
Cue Biopharma vs
Abintus Bio, Inc.
Abintus Bio, Inc. United States

Empowering patients from within

Venture round
11 employees
Biotechnology, Health Care
View all alternatives

FAQ About Cue Biopharma

Immune Responses, On Cue
Cue Biopharma was founded in 2014.
Cue Biopharma is headquartered in Boston, United States.
Cue Biopharma operates in Biopharma, Biotechnology, Health Care and Medical Devices.
Cue Biopharma has approximately 46 employees.
Top alternatives and competitors to Cue Biopharma include Umoja Biopharma, Harpoon Therapeutics, Abintus Bio, Inc., CRESCENDO BIOLOGICS LIMITED, Oxford BioTherapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cue Biopharma and Umoja Biopharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cue Biopharma, https://bouncewatch.com/company/cue-biopharma, updated 6 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout